EFNB1 and medulloblastoma: Considering that ephrin-B1 overexpression stimulates EphB activation, resulting in an alteration of F-actin distribution and morphology, attenuated adhesion, and enhancement of proliferation, the authors suggested ephrin-B1 as a potential target for the treatment of aggressive medulloblastoma subtypes resistant to conventional therapies [69].